Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas

NCT04471194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-12-13

Study results available
· View outcomes & findings →

Summary

In this study, the investigators will deliver self-sampling human papillomavirus (HPV) tests and fecal immunochemical test (FIT) kits, as well as adapted cancer screening educational materials, by mail to 110 women who are out-of-date for both cervical and colorectal cancer screenings, recruited through federally qualified health centers (FQHCs) in rural, segregated counties of Pennsylvania.

The hypothesis is that delivering self-sampling HPV tests and FIT, as well as adapted educational materials, to women in rural, segregated areas could help increase cancer screening, reduce geographic cancer disparities, and improve public health.

Conditions

  • Colorectal Cancer Screening
  • Cervical Cancer Screening

Interventions

DIAGNOSTIC_TEST

Self-sampling HPV test

Tests for human papillomavirus from cervical cell sample

DIAGNOSTIC_TEST

Fecal occult blood test

Tests for human hemoglobin from blood in fecal samples

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Jennifer Moss, PhD · Penn State College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-18
Primary Completion
2022-03-01
Completion
2022-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471194 on ClinicalTrials.gov